MRK

Merck & Company, Inc.

  • sector: Healthcare
  • exchange: NYSE
  • in 4 Arithmos indices

Indices that include MRK 4/4

sort
weight≥ 0.0%
alongside
  1. #1

    Defensive US Core 20

    MRK · 7.14%LLYWMTUNHCOST+9 more

    Merck & Co., Inc. — Healthcare.

    CAGR
    14.1%
    Sharpe
    0.84
    max DD
    -25.9%
  2. #2

    Recession-Resilient US Defensive 20 — Equal-Weighted

    MRK · 5.00%JNJABBVUNHABT+15 more

    Major pharmaceutical company with oncology and vaccine leadership (Keytruda); attractive valuation (P/E 15.5), 77% gross margin, and 3% dividend yield signal strong cash flow. Equal-weighted per user specification.

    CAGR
    8.6%
    Sharpe
    0.57
    max DD
    -26.3%
  3. #3

    Recession-Resilient US Defensive 20 — Equal-Weighted

    MRK · 5.00%PGKOPEPCL+15 more

    Major pharmaceutical company with $278B market cap and 77% gross margin. Equal-weighted at 5%; Keytruda and vaccine portfolio provide stable, recession-resilient revenue streams.

    CAGR
    2.5%
    Sharpe
    0.20
    max DD
    -14.2%
  4. #4

    AI Drug Discovery Index

    MRK · 10.00%RXRXSDGRABSICRSP+5 more

    Multiple AI partnerships across discovery and protein design.

    CAGR
    –
    Sharpe
    –
    max DD
    –

Build your own index that includes MRK.

Write a plain-English prompt, get transparent rules and a 10-year backtest.

start a prompt →

Performance figures are simulated backtests, not live returns. Past performance does not predict future results. Arithmos is a research and data tool, not investment advice.

/home·/markets·/feed·/leaderboard·/sharpe·/blog·/pricing·/about·/vacancies·/contact·/links·/terms
⚠Investment research & data tool · not investment advice · not a regulated broker or advisor · past performance does not guarantee future results.